Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
3,577
+74
+2% +$25.3K 0.07% 196
2026
Q1
$1.23M Buy
3,503
+68
+2% +$24.2K 0.08% 187
2025
Q4
$1.12M Buy
3,435
+214
+7% +$67.9K 0.07% 200
2025
Q3
$909K Sell
3,221
-715
-18% -$207K 0.06% 238
2025
Q2
$1.1M Sell
3,936
-1,392
-26% -$394K 0.08% 195
2025
Q1
$1.66M Buy
5,328
+748
+16% +$221K 0.14% 124
2024
Q4
$1.19M Buy
4,580
+10
+0.2% +$2.97K 0.1% 154
2024
Q3
$1.47M Buy
4,570
+344
+8% +$113K 0.15% 113
2024
Q2
$1.32M Buy
4,226
+1,631
+63% +$479K 0.14% 123
2024
Q1
$738K Buy
2,595
+543
+26% +$159K 0.08% 183
2023
Q4
$591K Buy
2,052
+760
+59% +$207K 0.07% 178
2023
Q3
$347K Buy
+1,292
New +$322K 0.05% 219
2023
Q1
Sell
-868
Closed -$228K 319
2022
Q4
$228K Buy
+868
New +$233K 0.04% 257
2019
Q3
Sell
-177
Closed -$29K 197
2019
Q2
$29K Sell
177
-40
-18% -$7.16K 0.02% 345
2019
Q1
$37K Sell
217
-66
-23% -$12.6K 0.02% 317
2018
Q4
$51K Buy
283
+14
+5% +$2.73K 0.03% 260
2018
Q3
$53K Sell
269
-28
-9% -$5.52K 0.03% 272
2018
Q2
$51K Buy
297
+7
+2% +$1.24K 0.03% 271
2018
Q1
$46K Buy
290
+52
+22% +$9.54K 0.03% 259
2017
Q4
$39K Buy
+238
New +$42.1K 0.03% 272

Other funds holding AMGN

Avestar Capital's AMGN Position: Q2 2026 in Review

Avestar Capital increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $25.3K and bringing the position to 3,577 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #196.

Avestar Capital first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.66M in Q1 2025. 1,514 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Avestar Capital held 3,577 shares of Amgen worth $1.3M as of Q2 2026.
  • Avestar Capital bought 74 Amgen shares in Q2 2026, an estimated $25.3K.
  • Amgen made up 0.07% of Avestar Capital's portfolio in Q2 2026, its #196 holding.
  • Avestar Capital first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
  • Avestar Capital's Amgen position peaked at $1.66M in Q1 2025.
  • 1,514 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.